1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Childhood Diffuse Large Cell Lymphoma: new trials by email Literature Review of Childhood Diffuse Large Cell Lymphoma trials Research Report on Childhood Diffuse Large Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia ifosfamide, etoposide, rituximab - B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Burkitt Lymphoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 82 | 2003-11-01 | 2013-10-08 |
Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Lymphoma, Large B-Cell, Diffuse (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1) · Histiocytic Disorders, Malignant (1) · Histiocytosis (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1)
Carboplatin (1) · Cytarabine (1) · Etoposide (1) · Filgrastim (1) · Ifosfamide (1) · Methotrexate (1) · Rituximab (1)
National Cancer Institute (NCI) (1)
United States (1)
Timothy Griffin (1)
U10CA098543 (1)